glp 1/gip agonist GLP-1 & GIP Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) gip/glp-1 agonists TrimRX
Description
Expert Opin Pharmacother (2014) 15:2487500
Abstract Obesity and type 2 diabetes mellitus (T2DM) are global health crises with significant morbidity and mortality
However, many patients have been found to have residual gastric contents after fasting, even when on stable doses
9-11 This review should be concluded with the acknowledgement of an important limitationthese trials had a relatively short duration
The remaining 309 articles underwent full-text assessment
